These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Current aspects of immunosuppressive therapy of collagen diseases]. Marmont A; Rossi F; Bordo D Minerva Med; 1973 Jun; 64(46):2436-50. PubMed ID: 4723570 [No Abstract] [Full Text] [Related]
4. [Our experiences in the treatment of various chronic nephropathies using immunosuppressive agents]. Mazdrakov G; Cukanov K Nar Zdrav; 1973; 29(2):38-42. PubMed ID: 4793472 [No Abstract] [Full Text] [Related]
5. [Treatment of systemic lupus erythematosus with immunosupressive agents. Results of our experience and review of the literature]. Kahn MF; Rambouts C; de Sèze S Sem Hop; 1971 Feb; 47(7):435-45. PubMed ID: 4323077 [No Abstract] [Full Text] [Related]
6. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of periodic disease with immuno-depressive agents]. Mamou H Sem Hop; 1970 Jun; 46(29):2030-4. PubMed ID: 4316965 [No Abstract] [Full Text] [Related]
11. [Treatment of polyarthritis by immunosuppressive agents]. Frei PC Schweiz Med Wochenschr; 1973 Aug; 103(33):1159-61. PubMed ID: 4751558 [No Abstract] [Full Text] [Related]
12. [Immunosuppressive therapy chronic polyarthritis]. Thumb N Wien Z Inn Med; 1972 Dec; ():Suppl:1-52. PubMed ID: 4574028 [No Abstract] [Full Text] [Related]
13. Responders to cyclophosphamide: results of a single-centre analysis among systemic sclerosis patients. Becker MO; Schohe A; Weinert K; Huscher D; Schneider U; Burmester GR; Riemekasten G Ann Rheum Dis; 2012 Dec; 71(12):2061-2. PubMed ID: 22689320 [No Abstract] [Full Text] [Related]
14. [Medicamental immunosuppression in dermatology (author's transl)]. Goerz G; Merk H Z Hautkr; 1981 Aug; 56(15):975-90. PubMed ID: 7269720 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide in scleroderma lung disease. Sullivan KM; McSweeney PA; Nash RA N Engl J Med; 2006 Sep; 355(11):1173-4; author reply 1174. PubMed ID: 16977701 [No Abstract] [Full Text] [Related]
16. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance]. Kahn MF; De Seze S Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281 [No Abstract] [Full Text] [Related]
17. Therapy of autoimmune nephropathy with steroids and cytostatics. A follow-up study of 80 patients and of 16 years. Petrányi G; Leövey A; Szegedi G; Kakuk G; Bobory J Acta Med Acad Sci Hung; 1971; 28(1):97-106. PubMed ID: 5133501 [No Abstract] [Full Text] [Related]
18. Cyclophosphamide in scleroderma lung disease. Andreu JL; Silva L N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16977700 [No Abstract] [Full Text] [Related]
19. Immunosuppressive therapy in severe rheumatoid arthritis. Dodson WH Mod Treat; 1971 Nov; 8(4):778-86. PubMed ID: 4946106 [No Abstract] [Full Text] [Related]
20. [Treatment of scleroderma and dermatomyositis in childhood]. Ansell BM Clin Ter; 1978 Jan; 84(2):123-31. PubMed ID: 648095 [No Abstract] [Full Text] [Related] [Next] [New Search]